Olivier Hermine

Olivier Hermine

Company: AB Science

Job title: Chief Scientific Officer

Seminars:

Exploring Mastocytosis & Kinases as the Basis of the History of Masitinib in ALS Mechanism of Action & Reviewing Clinical Results 3:30 pm

Investigating the mechanism of action of masitinib in ALS with the SOD1 rat model Assessing Masitinib to block the activity of tyrosine kinases and decrease nerve cell dysfunction in ALS Evaluating clinical results of Masitinib in combination therapyRead more

day: Day Two

Panel Discussion: Mechanisms, Targets, & Therapeutic Potential: Dissecting Exciting Opportunities to Drive Novel Therapeutic Strategies 11:00 am

Dissecting causative genes and cellular processes involved in ALS pathogenesis to shape future directions of therapeutic development C9orf72, SOD1 & TDP-43: mapping promising targets Can we move the needle in genetically defined patient populations and translate learnings to patients with sporadic ALS?Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.